Association between the extended tau haplotype and frontotemporal dementia

Archives of Neurology

Volumn 59, Issue 6, 2002, Pages 935-939

  Verpillat, Patrice ^a,b,c   Camuzat, Agnès ^c   Hannequin, Didier ^a,d   Thomas Anterion, Catherine ^e   Puel, Michèle ^f   Belliard, Serge ^g   Dubois, Bruno ^c   Didic, Mira ^a,h   Michel, Bernard François ⁱ   Lacomblez, Lucette ^c   Moreaud, Olivier ^j   Sellal, François ^k   Golfier, Véronique ^g   Campion, Dominique ^a   Clerget Darpoux, Françoise ^a   Brice, Alexis ^c  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^f CHU PURPAN   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h TIMONE HOSPITAL   (France)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

^j GRENOBLE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME 17; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

EID: 0036283019     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.6.935     Document Type: Article

References (44)

1. Dementia of frontal lobe type
2. Clinical and neuropathological criteria for frontotemporal dementia
3. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part X: Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease
4. Pick's disease versus Alzheimer's disease: A comparison of clinical characteristics
5. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
6. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E ε4 frequency, but no tau gene mutations
7. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
8. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
9. Tau is a candidate gene for chromosome 17 frontotemporal dementia
10. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
11. Phenotypic correlations in FTDP-17
12. Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10 + 11-splice site in the tau gene
13. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
14. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
15. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E ε4
16. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
17. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
18. The extended hapiotype of the microtubule associated protein tau gene is not associated with Pick's disease
19. Genetic evidence for the involvement of tau in progressive supranuclear palsy
20. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene
21. Direct genetic evidence for involvement of tau in progressive supranuclear palsy
22. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection
23. The tau gene A0 allele and progressive supranuclear palsy
24. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases
25. Progressive supranuclear palsy: Earlier age of onset in patients with the tau protein A0/A0 genotype
26. Mutational analysis of the tau gene in progressive supranuclear palsy
27. An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy
28. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
29. Significant association between the tau gene A0/A0 genotype and Parkinson's disease
30. Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer's disease
31. A polymorphism in the tau gene associated with risk for Alzheimer's disease
32. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans
33. No genetic association between polymorphisms in the tau gene and Alzheimer's disease in clinic or population based samples
34. No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease
35. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician
36. Genuine memory deficits in dementia
37. The FAB: A Frontal Assessment Battery at bedside
38. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
39. The neuropathologic diagnostic criteria of frontal lobe dementia revisited: A study of ten consecutive cases
40. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21
41. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia
42. Apolipoprotein E ε2 may be a risk factor for sporadic frontotemporal dementia
43. Apolipoprotein E gene and sporadic frontal lobe dementia